Non-pharmacological modification of cardiac risk factors: Part 3. Smoking cessation and alcohol consumption

Journal of Clinical Pharmacy and Therapeutics

Volumn 23, Issue 1, 1998, Pages 1-9

  Eagles, C J ^a   Martin, U ^b  

^a UNIVERSITY OF BEDFORDSHIRE   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN B; CHOLESTEROL; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ALCOHOL CONSUMPTION; BLOOD CLOTTING TIME; BODY FAT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COST BENEFIT ANALYSIS; HUMAN; HYPERTENSION; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; MORBIDITY; MORTALITY; REVIEW; RISK FACTOR; SMOKING CESSATION; VASCULAR ENDOTHELIUM; WEIGHT GAIN;

ADULT; AGED; ALCOHOL DRINKING; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CORONARY DISEASE; FEMALE; HUMANS; MIDDLE AGED; RISK FACTORS; SMOKING CESSATION; WEIGHT GAIN;

EID: 0031821455     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2710.1998.00137.x     Document Type: Review

References (90)

1. Manson JE, Tosteson H, Ridker PM, et al. (1993) The primary prevention of myocardial infarction. New England Journal of Medicine, 326, 1408-1416.
2. Negri E, La Vecchia C, D'Avanzo B, et al. (1994) Acute myocardial infarction: association with time since stopping smoking in Italy. Journal of Epidemiology and Community Health, 48, 129-133.
3. U.S. Department of Health and Human Services (1990) The Health Benefits of Smoking Cessation: a Report of the Surgeon General. Publication no. 90-8416. U.S. Dept of Health and Human Services (CDC), Rockville, MD.
4. Kupersmith J, Holmes-Rovener M, Hogan A, et al. (1995) Cost-effectiveness analysis in heart disease, part II. Preventive therapies. Progressions in Cardiovascular Disease, 37, 243-271.
5. Thun MJ, Peto R, Lopez AD, et al. (1997) Alcohol consumption and mortality among middle-aged and elderly U.S. adults. New England Journal of Medicine, 337, 1705-1714.
6. Doll R, Peto R, Wheatley K, et al. (1994) Mortality in relation to smoking: 40 years' observations on male British doctors. British Medical Journal, 309, 901-911.
7. Rigotti NA, Pasternak RC. (1996) Cigarette smoking and coronary heart disease: risks and management. Cardiological Clinics, 14, 51-68.
8. Kawachi I, Colditz GA, Stampfer MJ, et al. (1993) Smoking cessation in relation to total mortality rates in women. A prospective cohort study. Annals of Internal Medicine, 119, 992-1000.
9. Daly LE, Mulcahy R, Graham IM, et al. (1983) Long term effect on mortality of stopping smoking after unstable angina and myocardial infarction. British Medical Journal, 287, 324-326.
10. Aberg A, Bergstrand R, Johansson S, et al. (1983) Cessation of smoking after myocardial infarction: effects on mortality after 10 years. British Heart Journal, 49, 416-422.
11. Cavender JB, Rogers WJ, Fisher LD, et al. (1992) Effects of smoking on survival and morbidity in patients randomised to medical or surgical therapy in the coronary artery surgery study (CASS): 10-year follow-up. Journal of the American College of Cardiology, 20, 287-294.
12. Rosenberg L, Palmer JR, Shapiro S. (1990) Decline in risk of myocardial infarction among women who stop smoking. New England Journal of Medicine, 322, 213-217.
13. U.S. Department of Health and Human Services. (1989) Reducing the Health Consequences of Smoking: 25 years of progress. A report of the Surgeon General. Publication no. 89-8411. U.S. Department of Health and Human Services (CDC), Rockville, MD.
14. Kannel WB, McGee DL, Castelli WP. (1984) Latest perspective on cigarette smoking and cardiovascular disease: the Framingham study. Journal of Cardiac Rehabilitation, 4, 267-277.
15. Eliasson B, Attvall S, Taskinen MR, Smith U. (1997) Smoking cessation improves insulin sensitivity in healthy middle-aged men. European Journal of Clinical Investigation, 27, 450-456.
16. Auerbach O, Hammond EC, Garfinkel L. (1965) Smoking in relationship to atherosclerosis of the coronary arteries. New England Journal of Medicine, 273, 775-779.
17. Rhoads GG, Blackwelder WC, Stemmerma GH, et al. (1978) Coronary risk factors and autopsy findings in Japanese-American men. Laboratory Investigations, 38, 304-311.
18. Bellet S, DeGuzman MR, Kostis JB, et al. (1972) The effect of inhalation of cigarette smoke on ventricular fibrillation threshold in normal dogs and dogs with acute myocardial infarction. American Heart Journal, 83, 67-76.
19. Aronow WS, Kaplan NM. (1983) Smoking. In: Prevention of Coronary Heart Disease. Practical Management of the Risk Factors. eds Kaplan NM, Stamler J, pp. 51-60. Saunders, Philadelphia.
20. Davis RM. (1997) Passive smoking: history repeats itself (letter). British Medical Journal, 315, 961-962.
21. Law MR, Morris JK, Wald NJ. (1997) Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence. British Medical Journal, 315, 973-980.
22. Nilsson P, Lundgren H, Soderstrom M, et al. (1996) Effects of smoking cessation on insulin and cardiovascular risk factors - a controlled study of 4 months' duration. Journal of Internal Medicine, 240, 189-194.
23. Terres W, Becker P, Rosenberg A. (1994) Changes in cardiovascular risk profile during the cessation of smoking. American Journal of Medicine, 97, 242-249.
24. Green MS, Harari G. (1995) A prospective study of the effects of changes in smoking habits on blood count, serum lipids, and lipoproteins, body weight and blood pressure in occupationally active men. The Israeli CORDIS Study. Journal of Clinical Epidemiology, 48, 1159-1166.
25. McBride PE. (1992) The health consequences of smoking. Medical Clinics of North America, 76, 333-353.
26. Green MS, Jucha E, Luz Y. (1986) Blood pressure in smokers and non-smokers: epidemiological findings. American Heart Journal, 111, 932-940.
27. Benowitz NL, Sharp DS. (1989) Inverse relation between serum cotinine concentration and blood pressure in cigarette smokers. Circulation, 80, 1309-1312.
28. Cryer PE, Haymond MW, Santiago JV, et al. (1976) Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic event. New England Journal of Medicine, 295, 573-577.
29. Hansen KW, Pedersen MN, Christensen JS, Mogensen CE. (1994) Night blood pressure and cigarette smoking: disparate association in healthy subjects and diabetic patients. Blood Pressure, 3, 381-388.
30. Bloxham CA, Beevers DG, Walker JM. (1979) Malignant hypertension and cigarette smoking. British Medical Journal, 1, 581-583.
31. Wilhamson DF, Madans J, Anda RP, et al. (1991) Smoking cessation and severity of weight gain in a national cohort. New England Journal of Medicine, 324, 739-745.
32. Stamler J, Rains-Clearman D, Lenz-Litzow K, et al. (1997) Relation of smoking baseline and during trial years 1-6 to food and nutrient intakes and weight in the special intervention and usual care groups in the Multiple Risk Factor Intervention Trial. American Journal of Clinical Nutrition, 65 (Suppl. 1), 374-402.
33. Shimokata H, Muller DC, Andres R. (1989) Studies in the distribution of body fat. III. Effects of cigarette smoking. Journal of the American Medical Association, 261, 1169-1173.
34. Lissner L, Bengtsson C, Lapidus L, Bjorkelund C. (1992) Smoking initiation and cessation in relation to body fat distribution based on data from a study of Swedish women. American Journal of Public Health, 82, 273-275.
35. Meade TW, Imeson J, Stirling Y. (1987) Effects of smoking and other characteristics on clotting factors and the risk of ischaemic heart disease. Lancet, i, 986-988.
36. Lee AJ, Smith WCS, Lowe GDO, Tunstall-Pedoe H. (1990) Plasma fibrinogen and coronary risk factors: the Scottish Heart Study. Journal of Clinical Epidemiology, 43, 913-919.
37. Yamori Y, Mano M, Nara Y, Horie R. (1987) Catecholamine-induced polyploidization in vascular smooth muscle cells. Circulation, 75, 192-195.
38. Shimamoto T, Sunaga T. (1972) The contraction and blebbing of endothelial cells accompanied by acute infiltration of plasma substances into the vessel wall and their prevention. Excerpta Medica International Congress Serohgy, 269, 3-31.
39. Tracy RP, Psaty BM, Macy E, et al. (1997) Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arteriosclerosis Thrombosis and Vascular Biology, 17, 2167-2176.
40. Liuzzo C, Biasucci L, Gallimore J, et al. (1994) The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. New England Journal of Medicine, 331, 417-424.
41. Petitti DB, Kipp H. (1986) The leukocyte count: association with intensity of smoking and persistence of effect after quitting. American Journal of Epidemiology, 123, 89-95.
42. Davis JW, Shelton L, Eigenberg DA, et al. (1985) Effects of tobacco and non-tobacco cigarette smoking on endothelium and platelets. Clinical Pharmacology and Therapeutics, 37, 529-533.
43. Celermajer DS, Sorensen KH, Georgakopoulos D, et al. (1993) Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium dependent dilation in healthy young adults. Circulation, 88, 2149-2155.
44. Kiowski W, Linder L, Stoschitzky K, et al. (1994) Diminished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenously administered endothelin-1 in clinically healthy smokers. Circulation, 90, 27-34.
45. Chow KC. (1992) Vitamin E and cigarette smoking-induced oxidative damage. In: Vitamin E in Health and Disease. eds Packer L, Fuchs J, pp. 683-697. Marcel Decker, New York.
46. Stegmayr B, Johansson I, Huhtasaari F, Asplund K. (1993) Use of smokeless tobacco and cigarettes - effects on plasma levels of antioxidants vitamins. International Vitamin and Nutritional Research, 63, 195-200.
47. Verlangieri AJ, Bush MJ. (1992) Effects of d-alpha-to-copherol supplementation on experimentally induced primate atherosclerosis. Journal of the American College of Nutrition, 11, 131-138.
48. Eliasson B, Taskinen M-R, Smith U. (1996) Long-term use of nicotine gum is associated with hyperinsulinemia and insulin resistance. Circulation, 94, 878-881.
49. Klatsky AL, Armstrong MA, Friedman GD. (1990) Risk of cardiovascular mortality in alcohol drinkers, ex-drinkers, and nondrinkers. American Journal of Cardiology, 60, 1237-1242.
50. Poikolainen K. (1995) Alcohol and mortality: a review. Journal of Clinical Epidemiology, 48, 455-465.
51. Beaglehole R, Jackson R. (1992) Alcohol, cardiovascular diseases and all causes of mortality: a review of the epidemiological evidence. Drug and Alcohol Reviews, II, 275-290.
52. Kannel WB. (1988) Alcohol and Cardiovascular Disease. Proceedings of the Nutrition Society, 47, 99-110.
53. Kauhanen J, Kaplan GA, Goldberg DE, Salonen JT. (1997) Beer bingeing and mortality: results from the Kuopio ischaemic heart disease risk factor study, a prospective population based study. British Medical Journal, 315, 846-851.
54. Doll R, Peto R, Hall E, et al. (1994) Mortality in relation to consumption of alcohol: 13 years' observations on male British doctors. British Medical Journal, 309, 911-918.
55. Boffetta P, Garfinkel L. (1990) Alcohol drinking and mortality among men enrolled in an American Cancer Society prospective study. Epidemiology, 1, 342-348.
56. Sillanaukee P, Koivula T, Jokela H, et al. (1993) Relationship of alcohol consumption to changes in HDL-subfractions. European Journal of Clinical Investigation, 23, 486-491.
57. Gaziano MJ, Buring JE, Breslow JL, et al. (1993) Moderate alcohol intake, increased levels of high-density lipoproteins and its subfractions, and decreased risk of myocardial infarction. New England Journal of Medicine, 329, 1829-1834.
58. McConnell MV, Vavouranakis I, Wu LL, et al. (1997) Effects of a single, daily alcoholic beverage on lipid and hemostatic markers of cardiovascular risk. American Journal of Cardiology, 80, 1226-1228.
59. Miller NE, Hammett F, Saltissi S, et al. (1981) Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins. British Medical Journal, 282, 1741-1744.
60. Ballantyne FC, Clark RS, Simpson HS, Ballantyne D. (1982) High density and low density lipoprotein subtractions in survivors of myocardial infarction and in control subjects. Metabolism, 31, 433-437.
61. Haskell WL, Camargo C, Williams P, et al. (1984) The effect of cessation and resumption of moderate alcohol intake on serum high-density-lipoprotein subfractions. New England Journal of Medicine, 319, 805-810.
62. Hartung GH, Foreyt JP, Reeves RS, et al. (1990) Effects of alcohol dose on plasma lipoprotein subfractions in lipolytic enzyme activity in active and inactive men. Metabolism, 39, 81-86.
63. Hartung GH, Lawrence SJ, Reeves RS, Foreyt JP (1993) Effect of alcohol on postprandial lipemia and triglyceride clearance in men. Atherosclerosis, 100, 33-40.
64. Valimaaki M, Taskinen MR, Ylikahri R, et al. (1988) A comparison of the effects of two different doses of alcohol on serum lipoproteins, HDL-subfractions and apolipoproteines A-I and A-II: A controlled study. European Journal of Clinical Investigation, 18, 472-480.
65. Taskinen MR, Valimaki M, Nikkila EA, et al. (1982) High density lipoprotein subfractions and postheparin plasma Upases in alcoholic men before an after ethanol withdrawal. Metabolism, 31, 1168-1174.
66. Criqui MH, Cowan LD, Heiss G, et al. (1986) Frequency and clustering of non-lipid coronary risk factors in dyslipoproteinemia. The Lipid Research Clinics Program Prevelance Study. Circulation, 73, 1-40-1-50.
67. Kesaniemi YA, Kervinen K, Miettinen TA. (1987) Acetaldehyde modification of low density lipoprotein accelerates its catabolism in man. European Journal of Clinical Investigation, 17, 29-36.
68. Valimaki M, Laitinen K, Ylikahri R, et al. (1991) The effect of moderate alcohol intake on serum apolipoprotein A-I-containing lipoproteins and lipoprotein (a). Metabolism, 40, 1168-1172.
69. Lakshmanan MR, Ezekiel M. (1985) Effect of chronic ethanol feeding upon the catabolism of protein and lipid moieties of chylomicrons and very low density lipoproteins in vivo and in the perfused heart system. Alcoholism, 9, 327-330.
70. Valimaki M, Kahri J, Laitinen K, et al. (1993) High density lipoprotein subfractions, apolipoprotein A-I containing lipoproteins, lipoprotein (a), and cholesterol ester transfer protein activity in alcoholic women before and after ethanol withdrawal. European Journal of Clinical Investigation, 23, 406-417.
71. Klatsky AL. (1996) Alcohol and hypertension. Clinica Chimica Acta, 246, 91-105.
72. Klatsky AL, Friedman GD, Siegelaub AB, et al. (1977) Alcohol consumption and blood pressure. New England Journal of Medicine, 296, 1194-1200.
73. Hsieh ST, Saito K, Miyajima T, et al. (1995) Effects of alcohol moderation on blood pressure and intracellular cations in mild essential hypertension. American Journal of Hypertension, 8, 696-703.
74. Rajzer M, Kawecka-Jaszcz K, Czarnecka D, et al. (1997) Blood pressure, insulin resistance and left ventricular function in alcoholics. Journal of Hypertension, 15, 1219-1226.
75. Shen DC, Shieh SM, Fuh M, et al. (1988) Resistance to insulin-stimulated glucose uptake in patients with hypertension. Journal of Endocrinology and Metabolism, 66, 580-583.
76. Hendriks HFJ, Veenstra J, Velthuis-te Wierik EJM, et al. (1994) Effect of moderate dose of alcohol with evening meal on fibrinolytic factors. British Medical Journal, 308, 1003-1006.
77. Renaud S, de Lorgeril M. (1992) Wine, platelets, and the French paradox for coronary heart disease. Lancet, 339, 1523-1526.
78. McGarry GW, Gatehouse S, Hinnie J. (1994) Relation between alcohol and nose bleeds. British Medical Journal, 309, 640.
79. Frankel EN, Kanner J, German JB, et al. (1993) Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet, 341, 454-457.
80. Hillbom M, Kaste M, Tarssanen L, et al. (1983) Effect of ethanol on blood viscosity and erythrocyte flexibility in healthy men. European Journal of Clinical Investigation, 13, 45-48.
81. Hillbom M, Kangasaho M, Kaste M, et al. (1985) Acute ethanol ingestion increases platelet reactivity: is there a relationship to stroke? Stroke, 16, 19-23.
82. Moreyra AE, Kostis JB, Passanante AJ, Kuo PT. (1982) Acute myocardial infarction in patients with normal coronary arteries after acute ethanol intoxication. Clinical Cardiology, 5, 525-430.
83. Friedman GD, Klatsky AL. (1993) Is alcohol good for your health? New England Journal of Medicine, 329, 1882-1883.
84. Tofler GH, Brezinski D, Schafer AI, et al. (1987) Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. New England Journal of Medicine, 316, 1514-1518.
85. Seigneur M, Bonnet J, Dorian B, et al. (1990) Effect of the consumption of alcohol, white wine, and red wine on platelet function and serum lipids. Journal of Applied Cardiology, 5, 215-222.
86. Lecomte E, Herbeth B, Pirollet P, et al. (1994) Effect of alcohol consumption on blood antioxidant nutrients and oxidative stress indicators. American Journal of Clinical Nutrition, 60, 255-261.
87. Facchini F, Chen Y-DI, Reaven GM. (1994) Light-to-moderate alcohol intake is associated with enhanced insulin sensitivity. Diabetes Care, 17, 115-119.
88. Mayer EJ, Newman B, Quesenberry CP, et al. (1993) Alcohol consumption and insulin concentrations. Role of insulin in associations of alcohol intake with high-density lipoprotein cholesterol and triglycerides. Circulation, 88, 2190-2197.
89. Frolich JJ. (1996) Effects of alcohol on plasma lipoprotein metabolism. Clinica Chimica Acta, 246, 39-49.
90. Swade TF, Emanuele NV. (1997) Alcohol and diabetes. Comprehensive Therapy, 23, 135-140.